Health Ministry Proposes Separate Licence for Bulk-Drug Wholesalers

Conceptual bulk ingredient containers, a licence document and a magnifying glass representing supply-chain oversight.

NEW DELHI, November 19: Wholesalers of bulk pharmaceutical substances would need a dedicated licence under a draft framework outlined by the Union Health Ministry today. The proposal would separate their licensing from that for finished drug formulations.

Conceptual bulk ingredient containers, a licence document and a magnifying glass representing supply-chain oversight.
AI-generated representative image. Conceptual bulk-drug supply-chain oversight; not a photograph of a wholesaler or inspection.

A transition linked to final rules

Existing licence holders would move to the revised requirements after their current retention period ends or 12 months after final publication of the amendment, whichever is later, according to the ministry’s November 19 statement. That is a proposed transition arrangement, not a deadline already triggered by today’s announcement.

The ministry identifies the underlying draft as an amendment to the Drugs Rules, 1945, dated November 2, 2026. It proposes Form 19-BC for applications and Form 20-BC for licences covering active or inactive bulk substances.

What the licence would record

The proposed licence would identify the categories of bulk drugs handled by a wholesaler, including substances covered by the Narcotic Drugs and Psychotropic Substances Act, 1985. Sales would take place under a competent person’s personal supervision.

The ministry says the changes are intended to improve accountability in distribution and strengthen control over wholesale sales. Financial Express also reported the proposal on November 19.

Public comments before finalisation

Stakeholders and members of the public may send objections or suggestions to the Under Secretary (Drugs), Health Ministry, or to drugsdiv-mohfw@gov.in. The notice specifies 30 days from the date copies of the Gazette containing the draft are made available to the public. It does not describe that period as starting on November 19.

The dedicated licence remains a proposal pending finalisation. For related public policy developments, see our National section.

Photo: AI-generated representative image. Conceptual bulk-drug supply-chain oversight; not a photograph of a wholesaler or inspection.